Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Florbetapir F 18 PET in Progressive Cognitive Decline
NCT01400425Phase 3Completed
- Sponsor
- Avid Radiopharmaceuticals
- Start
- Jul 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Florbetapir in Alzheimer's disease (AD), sponsored by Avid Radiopharmaceuticals. Started Jul 2011; status: completed.
02
Drugs
Florbetapir
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01400425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01400425.